Atypical femur fractures associated with bisphosphonate therapy: post-operative outcomes

Eur J Orthop Surg Traumatol. 2023 Jul;33(5):1697-1703. doi: 10.1007/s00590-022-03314-y. Epub 2022 Jul 29.

Abstract

Purpose: Bisphosphonates are commonly used medication for the treatment of osteoporosis, and a well-established complication of this medication is bisphosphonate-associated atypical femur fractures (BAAFFs). The aim of this study was to assess the post-operative functional and radiographic outcomes of surgically treated BAAFFs.

Methods: An analysis of patients treated at a university-affiliated institution was performed. Patients who had undergone surgical fixation for a subtrochanteric or shaft of femur fracture which had been classified as atypical and treated with bisphosphonate therapy at the time of fracture were included. The outcome measures assessed included post-operative complications, length of stay, discharge destination, post-operative function, independence in activities of daily living (ADLs) and fracture union.

Results: Twenty patients were included in this study with a mean age of 75.2 years. The cohort was predominantly female. The average duration of bisphosphonate therapy was 7.35 years. Nine patients had contralateral bisphosphonate-related stress reactions at the time of their initial fracture and underwent prophylactic surgical intervention. The majority of patients received cephalomedullary nail fixation (95%) with more than half (65.0%) of the cohort experiencing one or more post-operative complications. The median length of stay was 6.5 days and 50% of the cohort required inpatient rehabilitation. At final review, independent mobilisation was recorded in only 10.0% of patients, and 70% of patients were dependent with their ADLs at their latest follow-up. Average follow-up was 8 months, and only six cases demonstrated union at the six-month review, with delayed union between 9 and 12 months being common.

Conclusion: Patients with BAAFFs experience high rates of complications, record poor post-operative functional outcomes, and demonstrate a delayed time to union. Nearly half of our cohort had radiographic evidence of bilateral pathology.

Keywords: Atypical femoral fracture; Bisphosphonate; Functional outcome; Radiological outcome.

MeSH terms

  • Activities of Daily Living
  • Aged
  • Bone Density Conservation Agents* / therapeutic use
  • Diphosphonates / adverse effects
  • Female
  • Femoral Fractures* / chemically induced
  • Femoral Fractures* / diagnostic imaging
  • Femoral Fractures* / surgery
  • Femur
  • Humans
  • Male
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Diphosphonates